Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00040066 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2017-01-11
Summary
The purpose of this study is to assess the development of human laboratory study model of cocaine relapse prevention.
Conditions
- Cocaine-Related Disorders
Interventions
- PROCEDURE
-
Cocaine (IV)
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
John Roache, Ph.D. · National Institute on Drug Abuse (NIDA)
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-05-31
- Completion
- 2003-08-31
Countries
- United States
Study Locations
More Related Trials
-
Topiramate to Reduce Cocaine Dependence
NCT00223626 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Effects in Humans: Physiology and Behavior - 1
NCT00000200 ·Status: COMPLETED ·Phase: PHASE2
-
Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
NCT00000303 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1
NCT00033046 ·Status: UNKNOWN ·Phase: PHASE1
-
Assessment of Potential Interactions Between Cocaine and Tolcapone - 1
NCT00033059 ·Status: UNKNOWN ·Phase: PHASE1
-
Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1
NCT00067535 ·Status: COMPLETED ·Phase: PHASE1
-
Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals
NCT00217997 ·Status: COMPLETED
-
Cocaethylene as a Treatment for Cocaine Dependence - 1
NCT00124696 ·Status: COMPLETED ·Phase: PHASE1
-
IV Cocaine Abuse: A Laboratory Model - 1
NCT00000212 ·Status: COMPLETED ·Phase: PHASE2
-
Modafinil Treatment for Cocaine-Dependent Individuals
NCT00129285 ·Status: COMPLETED ·Phase: PHASE2
-
IV Cocaine Abuse: A Laboratory Model - 3
NCT00000214 ·Status: COMPLETED ·Phase: PHASE2
-
Non-Treatment Study of Factors Affecting Cocaine Drug Choice
NCT00946660 ·Status: COMPLETED
-
Impulsivity, Neural Deficits and Cocaine Addiction
NCT00744601 ·Status: COMPLETED
-
Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4
NCT00000301 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.
NCT02255357 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1
NCT00032916 ·Status: UNKNOWN ·Phase: PHASE1
-
Stress and Medication Effects on Cocaine Cue Reactivity
NCT00613015 ·Status: COMPLETED ·Phase: PHASE2
-
Extending Long-term Outcomes Through an Adaptive Aftercare Intervention
NCT02143063 ·Status: COMPLETED ·Phase: NA
-
Cognitive Enhancement and Relapse Prevention in Cocaine Addiction
NCT01067846 ·Status: COMPLETED ·Phase: NA
-
Pharmacological Modulation of Cocaine Effects - 1
NCT00000201 ·Status: COMPLETED ·Phase: PHASE2
-
Alterations in Serotonergic Functions in Cocaine Addicts - 1
NCT00000312 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD)
NCT03242928 ·Status: COMPLETED ·Phase: PHASE2
-
Modeling Impaired Judgement in Cocaine Abusers - 6
NCT00015236 ·Status: COMPLETED ·Phase: PHASE4
-
Relapse Patterns in Female Cocaine Users - 4
NCT00000287 ·Status: COMPLETED
-
Reinforcing Effects of Cocaine During Phendimetrazine Maintenance
NCT02522325 ·Status: COMPLETED ·Phase: PHASE1